Transition-metal oxide (TMO) nanostructures have been widely investigated owing to their promising theoretical electrochemical behavior and high energy enactment. Furthermore, TMO-based nanostructures serve as positive electrode materials in the development of pseudocapacitor. The Co2V2O7 nanoparticles (NPs) and Co2V2O7/rGO nanocomposite (NC) electrodes have synthesized by hydrothermal process for enhanced supercapacitor performance. The crystalline structure, purity, and composition of existing elements are confirmed through Powder X-ray diffraction (PXRD), Furrier transform infrared spectroscopy (FTIR), Scanning electron microscope (SEM), and High resolution transmission electron microscope (HR-TEM) analyses. PXRD has revealed a monoclinic crystal structure with an average crystallite size of similar to 40 nm, whereas FTIR establish the existence of key functional groups. SEM and HR-TEM have displayed the formed spherical-like morphologies. Elemental compositional and oxidation state of the prepared NC have established by Energy dispersive X-ray spectroscopy (EDX) and X-ray photoelectron spectroscopy (XPS) analysis. The pseudocapacitive performance of the Co2V2O7/rGO electrode has evaluated in 1 M LiOH electrolyte solution, achieving a great specific capacitance 767.82 F/g at 1 A/g and 89.4% retaining with result of 5000 cycles. The prepared nanocomposite is used as the in an asymmetric supercapacitor (ACS) device, which delivered a specific capacitance of 97.61 F/g, electrode an energy density of 26.51 Wh/kg, and a power density of 1741.16 W/kg.
Let \(P_{k+1}\) denote a path of length \(k\), let \(S_{m}\) denote a star with \(m\) edges, and let \(K_{n}(\lambda)\) denote the complete multigraph on \(n\) vertices in which every edge is taken \(\lambda\) times. In this paper, we prove that the necessary conditions are also sufficient for a \(\{P_{4}, S_{4}\}\)-decomposition of \(K_{n}(\lambda)\).
Rosmarinic acid (RA) is a natural polyphenolic compound with potent antiviral properties against various viruses. This review comprehensively covers the mechanisms, evidence, and potential therapeutic use of RA. It exhibits strong antiviral effects by interfering with viral proteins and multiple stages of the viral life cycle, including direct virucidal activity, viral attachment and entry, viral replication enzymes, and the modulation of host immune responses. Its immunomodulatory and antioxidant effects enhance antiviral activity. It is particularly effective against enteroviruses, especially enterovirus 71 (EV-A71), by preventing the binding of viral capsid proteins to host cell receptors. Additionally, RA inhibits hepatitis B virus (HBV) by disrupting the epsilon RNA-polymerase complex. It may also be used against coronaviruses, including SARS-CoV-2, by inhibiting the main protease or modulating the inflammatory pathways. Preclinical studies have demonstrated the safety and efficacy of RA; however, limited clinical research exists, and issues such as bioavailability and standardization require further investigation. Advances in delivery systems and combination therapies have improved therapeutic outcomes. RA and its derivatives, namely salvianolic acid H, salvianolic acid B, mellitric acid A, sagerinic acid A, lithospermic acid, and rebdosiin, have Based on the review and in silico validation, RA is a promising natural antiviral agent with a multifaceted mode of action, warranting further research to develop preventive and therapeutic options against viral infections.
Start-up businesses play a crucial role in fostering innovation and economic growth; however, access to financial support remains a major challenge, particularly in emerging entrepreneurial hubs such as Bangalore. This study examines the financial access challenges faced by startup businesses in Bangalore by identifying the key factors that restrict their ability to obtain external finance. Primary data were collected through a structured questionnaire from startup founders and financial decision-makers, and the data were analyzed using exploratory factor analysis. The results show that problems like difficulties in getting loans from institutions, high financing costs, lack of information and awareness, complicated procedures, issues with creditworthiness, and challenges in getting equity financing greatly affect how The findings corroborate earlier studies and provide region-specific insights that can assist policymakers, financial institutions, and entrepreneurs in strengthening the startup financing ecosystem.
The present work involves the synthesis of six Schiff base ligands through the condensation of 2-hydroxy-1,2-di(phenyl)ethanone and diamine derivatives. Microelemental analysis, UV–Visible, FT-IR, NMR, EI, and Mass spectral studies were employed to characterize all the synthesized compounds. As very effective corrosive inhibitors of mild steel corrosion, they were used after their identification and biological assessment. The weight loss method was used to evaluate the inhibitory efficiency. Additionally, the surface morphology was examined using a scanning electron microscope (SEM). The calculated Gibbs free energy value validates the chemical nature of the adsorption, and the adsorption of BPA on the carbon steel surface was consistent with the Langmuir adsorption isotherm model. The charge in the impedance parameters (Rt and Cdl) with BPA concentrations was indicative, according to the EIS data. A protective layer forms on the surface of carbon steel as a result of this molecule's adsorption. Surface morphology investigations have also been used to support the electrochemical data. According to EIS analysis, resistance increased as inhibitor concentration increased, indicating the creation of a protective layer at the C-S/HCl interface. Polarisation curves show that the inhibitor impacts both the cathodic and anodic corrosion currents. Several factors influence the inhibition efficiency of the inhibitor, including the concentration, molecular weight, double bond conjugation, and amount of nitrogen it contains. The hydroxyl and N, N-dimethylamino substituent ligand achieved 98
